Please use this identifier to cite or link to this item: https://hdl.handle.net/2445/214874
Title: Delabelling beta-lactam allergy
Author: Molina Molina, Gustavo Jorge
Garnica Velandia, Diana Rocío
Andrés López, Blanca
Perales, Carolina
Marín Asensio, Laura
Jurgens, Yanina
Esteso, Olga
Escobar, Carolina
Vidal, Xavier
Vendrell, Lourdes
Gómez Ganda, Laura
Rodríguez, Dolores
Montané, Eva
Cardona, Victoria
Agustí, Antònia
Keywords: Al·lèrgia als medicaments
Antibiòtics betalactàmics
Drug allergy
Beta lactam antibiotics
Issue Date: 27-Jun-2024
Publisher: Frontiers Media SA
Abstract: Background: Hypersensitivity to beta-lactam (BL) antibiotics is one of the most frequent reported drug allergies. In our population, it is common to find labels of BL allergy in electronic medical records (EMRs) that have not been assessed. The objective of our study was to detect patients with beta-lactam allergy labels in their EMRs and to assess how many of them are false after a correct diagnostic evaluation.Methods: A multicentre prospective study was performed with patients labelled as allergic to BLs in their EMRs in the previous 5 years. Demographical and clinical data, as well as variables regarding the BL allergy label and the characteristics of the index reaction from clinical history and EMRs, were recorded. Then, diagnostic assessments including clinical history, skin tests (STs), and drug provocation tests (DPTs) were conducted in order to confirm or exclude the diagnosis of BL allergy.Results: A total of 249 patients completed the study, of which 160 (64.3%) were women with a median age of 57 years (interquartile range [IQR], 45-68). The most frequent BL allergy labels detected were for penicillin (124), amoxicillin/clavulanic acid (61), and amoxicillin (54). Of the 204 patients who underwent STs, 20.1% were positive. DPTs were performed in 224 patients, showing good tolerance in 87.1% of cases. After the allergy diagnosis work-up, 186 patients (74.7%) were diagnosed as non-allergic to BL antibiotics.Conclusion: In our study population, the number of patients labelled as allergic to BLs in their EMRs was similar to that in previously published studies, with proportions near to 75%-80% being falsely labelled as allergic to BLs.
Note: Reproducció del document publicat a: https://doi.org/10.3389/fphar.2024.1423719
It is part of: Frontiers in Pharmacology, 2024, vol. 15
URI: https://hdl.handle.net/2445/214874
Related resource: https://doi.org/10.3389/fphar.2024.1423719
ISSN: 1663-9812
Appears in Collections:Articles publicats en revistes (Institut d'lnvestigació Biomèdica de Bellvitge (IDIBELL))

Files in This Item:
File Description SizeFormat 
fphar-15-1423719.pdf1.81 MBAdobe PDFView/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.